FACTS ABOUT SECTION BOX REVEALED

secobarbital will lessen the level or effect of mavacamten by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.secobarbital will decrease the level or effect of atogepant by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep an eye on Intently. Advisable atogepant dosage with concomitant usage of potent